Page last updated: 2024-12-06

phorbol-12,13-dibenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Phorbol-12,13-dibenzoate (PDB) is a potent tumor promoter. It is a synthetic derivative of phorbol, a diterpene found in plants of the genus *Croton*. PDB acts as a strong activator of protein kinase C (PKC), a family of serine/threonine-specific protein kinases that are involved in various cellular processes, including cell growth, differentiation, and apoptosis. The compound is a valuable tool for studying the role of PKC in different biological processes. PDB has been used extensively in research to investigate the mechanisms of tumor promotion and the role of PKC in cancer development. However, due to its high toxicity, PDB is not used therapeutically. The synthesis of PDB involves the esterification of phorbol with benzoic acid. This reaction is typically carried out under acidic conditions. The resulting product is a white solid that is soluble in organic solvents. PDB has been shown to induce a variety of biological effects, including cell proliferation, tumor promotion, and inflammation. These effects are mediated by the activation of PKC. The importance of PDB lies in its ability to activate PKC and induce a wide range of biological responses. This makes it a valuable tool for studying the role of PKC in various cellular processes. The compound is also used in cancer research to investigate the mechanisms of tumor promotion and the development of new cancer therapies.'

Cross-References

ID SourceID
PubMed CID72294
CHEMBL ID445729
SCHEMBL ID2405620
MeSH IDM0053101

Synonyms (16)

Synonym
phorbol, 12,13-dibenzoate
phorbol-12,13-dibenzoate
5h-cyclopropa(3,4)benz(1,2-e)azulen-5-one, 9,9a-bis(benzoyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-, (1ar-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-
5h-cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-9,9a-bis(benzoyloxy)-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-, (1ar-(1a-alpha,4b-beta,4a-beta,7a-alpha,7b-alpha,8-alpha,9-beta,9a-alpha))
ccris 695
nsc 262643
9,9a-bis(benzoyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5h-cyclopropa(3,4)benz(1,2-e)azulen-5-one (1ar-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-
5h-cyclopropa[3,4]benz[1,2-e]azulen-5-one, 9,9a-bis(benzoyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-, (1ar,1bs,4ar,7as,7bs,8r,9r,9as)-
4-.beta.-phorbol 12,13-dibenzoate
4.b.-phorbol 12,13-dibenzoate
25405-85-0
NSC262643 ,
CHEMBL445729
SCHEMBL2405620
[(1s,2s,6r,10s,11r,13s,14r,15r)-13-benzoyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] benzoate
DTXSID801313084
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID380909Toxicity against Swiss-Webster mouse assessed as irritation in ear per 5 ul after 24 hrs
AID380908Toxicity against Swiss-Webster mouse assessed as irritation in ear per 5 ul after 4 hrs
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (73.33)18.7374
1990's3 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.33 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]